TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7755741
log Bayes Factor = 37.5191
Chromosome 6   position 26,337,264  (GRCh37) Explore rs7755741 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.003 0.997
K90 Intestinal malabsorption
0.000 0.579 0.421
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.628 0.372
K90.3 Pancreatic steatorrhoea
0.000 0.698 0.302
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.698 0.302
K90.1 Tropical sprue
0.000 0.698 0.302
K90.9 Intestinal malabsorption, unspecified
0.000 0.762 0.238
I10 Essential (primary) hypertension
0.000 0.774 0.226
K90.8 Other intestinal malabsorption
0.000 0.778 0.221
E83 Disorders of mineral metabolism
0.000 0.899 0.101
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.927 0.072
E83.8 Other disorders of mineral metabolism
0.000 0.927 0.072
E83.2 Disorders of zinc metabolism
0.000 0.927 0.072
E83.0 Disorders of copper metabolism
0.000 0.927 0.072
E83.3 Disorders of phosphorus metabolism
0.000 0.931 0.069
E11 Non-insulin-dependent diabetes mellitus
0.000 0.958 0.042
E11.2 With renal complications
0.000 0.960 0.040
E11.5 With peripheral circulatory complications
0.000 0.961 0.039
I10-I15 Hypertensive diseases
0.000 0.961 0.039
E11.4 With neurological complications
0.000 0.964 0.036
E11.9 Without complications
0.000 0.964 0.036
E11.6 With other specified complications
0.000 0.965 0.035
K90-K93 Other diseases of the digestive system
0.000 0.966 0.034
E10-E14 Diabetes mellitus
0.000 0.968 0.032
E11.0 With coma
0.000 0.969 0.031
E11.7 With multiple complications
0.000 0.970 0.030
E83.4 Disorders of magnesium metabolism
0.000 0.970 0.030
I11 Hypertensive heart disease
0.000 0.970 0.029
E11.1 With ketoacidosis
0.000 0.971 0.029
E11.3 With ophthalmic complications
0.000 0.971 0.029
I13 Hypertensive heart and renal disease
0.000 0.972 0.028
E14 Unspecified diabetes mellitus
0.000 0.972 0.028
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.973 0.027
E14.3 With ophthalmic complications
0.000 0.974 0.026
C85.1 B-cell lymphoma, unspecified
0.000 0.975 0.025
E11.8 With unspecified complications
0.000 0.975 0.024
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.976 0.024
E14.1 With ketoacidosis
0.000 0.976 0.024
E14.5 With peripheral circulatory complications
0.000 0.976 0.023
E10 Insulin-dependent diabetes mellitus
0.000 0.977 0.023
E14.6 With other specified complications
0.000 0.977 0.023
E83.5 Disorders of calcium metabolism
0.000 0.977 0.023
E12 Malnutrition-related diabetes mellitus
0.000 0.977 0.023
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.977 0.023
E10.5 With peripheral circulatory complications
0.000 0.978 0.022
E16.2 Hypoglycaemia, unspecified
0.000 0.979 0.021
E10.0 With coma
0.000 0.979 0.021
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.979 0.021
I15 Secondary hypertension
0.000 0.979 0.021
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.979 0.021
E13 Other specified diabetes mellitus
0.000 0.979 0.021
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.979 0.021
C83.3 Large cell (diffuse)
0.000 0.980 0.020
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.980 0.020
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.980 0.020
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.980 0.020
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.980 0.020
E14.7 With multiple complications
0.000 0.980 0.020
E14.0 With coma
0.000 0.980 0.020
E14.8 With unspecified complications
0.000 0.980 0.020
C81 Hodgkin's disease
0.000 0.981 0.019
C83.7 Burkitt's tumour
0.000 0.981 0.019
E16 Other disorders of pancreatic internal secretion
0.000 0.981 0.019
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.000 0.981 0.019
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.981 0.019
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.982 0.018
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.982 0.018
C82.2 Large cell, follicular
0.000 0.982 0.018
E10.3 With ophthalmic complications
0.000 0.982 0.018
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.982 0.018
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.982 0.018
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.982 0.018
K93.1 Megacolon in Chagas' disease
0.000 0.982 0.018
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.982 0.018
M65.9 Synovitis and tenosynovitis, unspecified
0.000 0.982 0.018
E14.4 With neurological complications
0.000 0.982 0.017
C93 Monocytic leukaemia
0.000 0.983 0.017
C82.0 Small cleaved cell, follicular
0.000 0.983 0.017
E10.1 With ketoacidosis
0.000 0.983 0.017
M65.94 Synovitis and tenosynovitis, unspecified (Hand)
0.000 0.983 0.017
E10.7 With multiple complications
0.000 0.983 0.017
C81.0 Lymphocytic predominance
0.000 0.983 0.017
E70-E90 Metabolic disorders
0.000 0.983 0.017
E12.9 Without complications
0.000 0.983 0.016
E12.8 With unspecified complications
0.000 0.983 0.016
E12.7 With multiple complications
0.000 0.983 0.016
E12.6 With other specified complications
0.000 0.983 0.016
E12.5 With peripheral circulatory complications
0.000 0.983 0.016
E12.4 With neurological complications
0.000 0.983 0.016
E12.3 With ophthalmic complications
0.000 0.983 0.016
E12.2 With renal complications
0.000 0.983 0.016
E12.1 With ketoacidosis
0.000 0.983 0.016
E12.0 With coma
0.000 0.983 0.016
E14.2 Withrenal complications
0.000 0.983 0.016
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.983 0.016
C85.0 Lymphosarcoma
0.000 0.983 0.016
E10.8 With unspecified complications
0.000 0.984 0.016
C81.1 Nodular sclerosis
0.000 0.984 0.016
C83.1 Small cleaved cell (diffuse)
0.000 0.984 0.016
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.984 0.016
C88 Malignant immunoproliferative diseases
0.000 0.984 0.016
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.984 0.016
K70.4 Alcoholic hepatic failure
0.000 0.984 0.016
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)
0.000 0.984 0.016
K70.0 Alcoholic fatty liver
0.000 0.984 0.016
K70 Alcoholic liver disease
0.000 0.984 0.016
E40-E46 Malnutrition
0.000 0.984 0.016
C81.9 Hodgkin's disease, unspecified
0.000 0.985 0.015
K70.9 Alcoholic liver disease, unspecified
0.000 0.985 0.015
C83.6 Undifferentiated (diffuse)
0.000 0.985 0.015
C83.5 Lymphoblastic (diffuse)
0.000 0.985 0.015
C83.4 Immunoblastic (diffuse)
0.000 0.985 0.015
C83.2 Mixed small and large cell (diffuse)
0.000 0.985 0.015
C82.4 Follicular lymphoma grade IIIb
0.000 0.985 0.015
D45 Polycythaemia vera
0.000 0.985 0.015
C93.1 Chronic monocytic leukaemia
0.000 0.985 0.015
I15.8 Other secondary hypertension
0.000 0.985 0.015
I15.2 Hypertension secondary to endocrine disorders
0.000 0.985 0.015
E13.8 With unspecified complications
0.000 0.985 0.015
E13.7 With multiple complications
0.000 0.985 0.015
E13.6 With other specified complications
0.000 0.985 0.015
E13.5 With peripheral circulatory complications
0.000 0.985 0.015
E13.4 With neurological complications
0.000 0.985 0.015
E13.3 With ophthalmic complications
0.000 0.985 0.015
E13.2 With renal complications
0.000 0.985 0.015
E13.1 With ketoacidosis
0.000 0.985 0.015
E13.0 With coma
0.000 0.985 0.015
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.985 0.015
C94 Other leukaemias of specified cell type
0.000 0.985 0.015
C82.6 Cutaneous follicle centre lymphoma
0.000 0.985 0.015
C82.5 Diffuse follicle centre lymphoma
0.000 0.985 0.015
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)
0.000 0.985 0.015
E10.6 With other specified complications
0.000 0.985 0.015
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.985 0.015
I15.9 Seconday hypertension, unspecified
0.000 0.985 0.014
C81.7 Other Hodgkin's disease
0.000 0.986 0.014
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.986 0.014
C81.3 Lymphocytic depletion
0.000 0.986 0.014
C81.2 Mixed cellularity
0.000 0.986 0.014
C86 Other specified types of T/NK-cell lymphoma
0.000 0.986 0.014
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.986 0.014
I15.0 Renovascular hypertension
0.000 0.986 0.014
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.986 0.014
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.986 0.014
E16.4 Abnormal secretion of gastrin
0.000 0.986 0.014
E16.3 Increased secretion of glucagon
0.000 0.986 0.014
C95 Leukaemia of unspecified cell type
0.000 0.986 0.014
E46 Unspecified protein-energy malnutrition
0.000 0.986 0.014
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.986 0.014
C82.3 Follicular lymphoma grade IIIa
0.000 0.986 0.014
E10.4 With neurological complications
0.000 0.986 0.014
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.986 0.013
E73 Lactose intolerance
0.000 0.987 0.013
E15 Nondiabetic hypoglycaemic coma
0.000 0.987 0.013
E16.1 Other hypoglycaemia
0.000 0.987 0.013
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.987 0.013
E88 Other metabolic disorders
0.000 0.987 0.013
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)
0.000 0.987 0.013
M65.98 Synovitis and tenosynovitis, unspecified (Other)
0.000 0.987 0.013
E13.9 Without complications
0.000 0.987 0.013
C93.9 Monocytic leukaemia, unspecified
0.000 0.987 0.013
C93.7 Other monocytic leukaemia
0.000 0.987 0.013
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.987 0.013
C93.2 Subacute monocytic leukaemia
0.000 0.987 0.013
C93.0 Acute monocytic leukaemia
0.000 0.987 0.013
E84 Cystic fibrosis
0.000 0.987 0.013
E80.4 Gilbert's syndrome
0.000 0.987 0.013
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)
0.000 0.987 0.012
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.987 0.012
H57.8 Other specified disorders of eye and adnexa
0.012 0.988 0.000
E79 Disorders of purine and pyrimidine metabolism
0.000 0.988 0.012
E77 Disorders of glycoprotein metabolism
0.000 0.988 0.012
E76 Disorders of glycosaminoglycan metabolism
0.000 0.988 0.012
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.988 0.012
E70 Disorders of aromatic amino-acid metabolism
0.000 0.988 0.012
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.988 0.012
H57 Other disorders of eye and adnexa
0.012 0.988 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.000 0.988 0.012
E10.2 With renal complications
0.000 0.988 0.012
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)
0.000 0.988 0.012
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.988 0.012
C88.7 Other malignant immunoproliferative diseases
0.000 0.988 0.012
C88.3 Immunoproliferative small intestinal disease
0.000 0.988 0.012
C88.2 Gamma heavy chain disease
0.000 0.988 0.012
C88.1 Alpha heavy chain disease
0.000 0.988 0.012
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.000 0.988 0.012
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.988 0.012
I12 Hypertensive renal disease
0.000 0.988 0.012
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.000 0.988 0.012
H57.0 Anomalies of pupillary function
0.012 0.988 0.000
D47.3 Essential (haemorrhagic) thrombocythaemia
0.000 0.988 0.012
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.988 0.011
K70.3 Alcoholic cirrhosis of liver
0.000 0.989 0.011
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.989 0.011
E45 Retarded development following protein-energy malnutrition
0.000 0.989 0.011
E43 Unspecified severe protein-energy malnutrition
0.000 0.989 0.011
E42 Marasmic kwashiorkor
0.000 0.989 0.011
E41 Nutritional marasmus
0.000 0.989 0.011
E40 Kwashiorkor
0.000 0.989 0.011
H57.9 Disorder of eye and adnexa, unspecified
0.011 0.989 0.000
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.989 0.011
C94.7 Other specified leukaemias
0.000 0.989 0.011
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.989 0.011
C94.5 Acute myelofibrosis
0.000 0.989 0.011
C94.4 Acute panmyelosis
0.000 0.989 0.011
C94.3 Mast cell leukaemia
0.000 0.989 0.011
C94.2 Acute megakaryoblastic leukaemia
0.000 0.989 0.011
C94.1 Chronic erythraemia
0.000 0.989 0.011
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.989 0.011
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.989 0.011
C96.8 Histiocytic sarcoma
0.000 0.989 0.011
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.989 0.011
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.989 0.011
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.989 0.011
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.989 0.011
C96.3 True histiocytic lymphoma
0.000 0.989 0.011
C96.2 Malignant mast cell tumour
0.000 0.989 0.011
C96.1 Malignant histiocytosis
0.000 0.989 0.011
C96.0 Letterer-Siwe disease
0.000 0.989 0.011
I15.1 Hypertension secondary to other renal disorders
0.000 0.989 0.011
K70.1 Alcoholic hepatitis
0.000 0.989 0.011
E73.9 Lactose intolerance, unspecified
0.000 0.989 0.011
C92 Myeloid leukaemia
0.000 0.989 0.011
N85.0 Endometrial glandular hyperplasia
0.011 0.989 0.000
E72 Other disorders of amino-acid metabolism
0.000 0.989 0.011
D46 Myelodysplastic syndromes
0.000 0.989 0.011
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.989 0.011
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.989 0.011
E88.8 Other specified metabolic disorders
0.000 0.989 0.011
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.000 0.989 0.011
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.989 0.010
E80.2 Other porphyria
0.000 0.990 0.010
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.000 0.990 0.010
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.990 0.010
C86.4 Blastic NK-cell lymphoma
0.000 0.990 0.010
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.990 0.010
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.990 0.010
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.990 0.010
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.990 0.010
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.990 0.010
H57.1 Ocular pain
0.010 0.990 0.000
D39.1 Ovary
0.000 0.990 0.010
C95.7 Other leukaemia of unspecified cell type
0.000 0.990 0.010
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.990 0.010
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.990 0.010
C95.0 Acute leukaemia of unspecified cell type
0.000 0.990 0.010
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.990 0.010
E80.5 Crigler-Najjar syndrome
0.000 0.990 0.010
E80.3 Defects of catalase and peroxydase
0.000 0.990 0.010
E80.1 Porphyria cutanea tarda
0.000 0.990 0.010
E80.0 Hereditary erythropoietic porphyria
0.000 0.990 0.010
C83.0 Small cell (diffuse)
0.000 0.990 0.010
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.990 0.010
D47.2 Monoclonal gammopathy
0.000 0.990 0.010
E74 Other disorders of carbohydrate metabolism
0.000 0.990 0.010
M65 Synovitis and tenosynovitis
0.000 0.990 0.010
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.990 0.010
D44.3 Pituitary gland
0.000 0.990 0.010
E73.8 Other lactose intolerance
0.000 0.990 0.010
E73.1 Secondary lactase deficiency
0.000 0.990 0.010
E73.0 Congenital lactase deficiency
0.000 0.990 0.010
E84.9 Cystic fibrosis, unspecified
0.000 0.990 0.010
D39.0 Uterus
0.000 0.990 0.010
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.990 0.009
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.990 0.009
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.990 0.009
C84.3 Lymphoepithelioid lymphoma
0.000 0.990 0.009
C84.2 T-zone lymphoma
0.000 0.990 0.009
C84.1 Sezary's diease
0.000 0.990 0.009
E88.9 Metabolic disorder, unspecified
0.000 0.990 0.009
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.991 0.009
E75.5 Other lipid storage disorders
0.000 0.991 0.009
N18.3 Chronic kidney disease, stage 3
0.000 0.991 0.009
E65-E68 Obesity and other hyperalimentation
0.000 0.991 0.009
E84.8 Cystic fibrosis with other manifestations
0.000 0.991 0.009
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.991 0.009
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.991 0.009
C84.0 Mycosis fungoides
0.000 0.991 0.009
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.991 0.009
E75.6 Lipid storage disorder, unspecified
0.000 0.991 0.009
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.991 0.009
E75.3 Sphingolipidosis, unspecified
0.000 0.991 0.009
E75.2 Other sphingolipidosis
0.000 0.991 0.009
E75.1 Other gangliosidosis
0.000 0.991 0.009
E75.0 GM2 gangliosidosis
0.000 0.991 0.009
E88.3 Tumour lysis syndrome
0.000 0.991 0.009
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.000 0.991 0.009
C95.9 Leukaemia, unspecified
0.000 0.991 0.009
D46.9 Myelodysplastic syndrome, unspecified
0.000 0.991 0.009
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.991 0.009
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.991 0.009
E70.3 Albinism
0.000 0.991 0.009
E70.2 Disorders of tyrosine metabolism
0.000 0.991 0.009
E70.1 Other hyperphenylalaninaemias
0.000 0.991 0.009
E70.0 Classical phenylketonuria
0.000 0.991 0.009
E71.3 Disorders of fatty-acid metabolism
0.000 0.991 0.009
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.991 0.009
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.991 0.009
E71.0 Maple-syrup-urine disease
0.000 0.991 0.009
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.991 0.009
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.991 0.009
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.991 0.009
E76.2 Other mucopolysaccharidoses
0.000 0.991 0.009
E76.1 Mucopolysaccharidosis, type II
0.000 0.991 0.009
E76.0 Mucopolysaccharidosis, type I
0.000 0.991 0.009
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.991 0.009
E77.8 Other disorders of glycoprotein metabolism
0.000 0.991 0.009
E77.1 Defects in glycoprotein degradation
0.000 0.991 0.009
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.991 0.009
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.991 0.009
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.991 0.009
E79.1 Lesch-Nyhan syndrome
0.000 0.991 0.009
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.000 0.991 0.009
D39.7 Other female genital organs
0.000 0.991 0.009
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.991 0.009
D41.0 Kidney
0.000 0.991 0.009
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.991 0.009
C84.5 Other and unspecified T-cell lymphomas
0.000 0.991 0.009
E80.6 Other disorders of bilirubin metabolism
0.000 0.991 0.009
D37.6 Liver, gallbladder and bile ducts
0.000 0.991 0.009
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.000 0.991 0.009
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.000 0.991 0.009
D39.9 Female genital organ, unspecified
0.000 0.991 0.008
D39.2 Placenta
0.000 0.991 0.008
E88.2 Lipomatosis, not elsewhere classified
0.000 0.991 0.008
E44.1 Mild protein-energy malnutrition
0.000 0.992 0.008
E44.0 Moderate protein-energy malnutrition
0.000 0.992 0.008
D46.7 Other myelodysplastic syndromes
0.000 0.992 0.008
D46.2 Refractory anaemia with excess of blasts
0.000 0.992 0.008
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.992 0.008
D41.4 Bladder
0.000 0.992 0.008
E20-E35 Disorders of other endocrine glands
0.000 0.992 0.008
C84.4 Peripheral T-cell lymphoma
0.000 0.992 0.008
D37.7 Other digestive organs
0.000 0.992 0.008
D44.7 Aortic body and other paraganglia
0.000 0.992 0.008
D46.1 Refractory anaemia with sideroblasts
0.000 0.992 0.008
M65.4 Radial styloid tenosynovitis [de Quervain]
0.000 0.992 0.008
D44.0 Thyroid gland
0.000 0.992 0.008
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.992 0.008
C92.7 Other myeloid leukaemia
0.000 0.992 0.008
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.992 0.008
C92.5 Acute myelomonocytic leukaemia
0.000 0.992 0.008
C92.3 Myeloid sarcoma
0.000 0.992 0.008
C92.2 Subacute myeloid leukaemia
0.000 0.992 0.008
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)
0.000 0.992 0.008
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.992 0.008
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.992 0.008
E72.5 Disorders of glycine metabolism
0.000 0.992 0.008
E72.4 Disorders of ornithine metabolism
0.000 0.992 0.008
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.992 0.008
E72.2 Disorders of urea cycle metabolism
0.000 0.992 0.008
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.992 0.008
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
0.000 0.992 0.008
D46.5 Refractory anaemia with multi-lineage dysplasia
0.000 0.992 0.008
D46.4 Refractory anaemia, unspecified
0.000 0.992 0.008
D46.3 Refractory anaemia with excess of blasts with transformation
0.000 0.992 0.008
D46.0 Refractory anaemia without sideroblasts, so stated
0.000 0.992 0.008
Z75.1 Person awaiting admission to adequate facility elsewhere
0.000 0.992 0.008
D47.4 Osteomyelofibrosis
0.000 0.992 0.008
D44.9 Endocrine gland, unspecified
0.000 0.992 0.008
D44.5 Pineal gland
0.000 0.992 0.008
D44.2 Parathyroid gland
0.000 0.992 0.008
K91.1 Postgastric surgery syndromes
0.000 0.992 0.008
D44.6 Carotid body
0.000 0.992 0.008
D05.9 Carcinoma in situ of breast, unspecified
0.008 0.992 0.000
D41.9 Urinary organ, unspecified
0.000 0.992 0.008
D41.7 Other urinary organs
0.000 0.992 0.008
D41.3 Urethra
0.000 0.992 0.008
D41.1 Renal pelvis
0.000 0.992 0.008
M65.8 Other synovitis and tenosynovitis
0.000 0.992 0.008
K91.5 Postcholecystectomy syndrome
0.000 0.992 0.008
E65 Localised adiposity
0.000 0.992 0.008
D44.4 Craniopharyngeal duct
0.000 0.992 0.008
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.992 0.007
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.000 0.992 0.007
C92.1 Chronic myeloid leukaemia
0.000 0.992 0.007
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.992 0.007
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.992 0.007
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.992 0.007
E74.2 Disorders of galactose metabolism
0.000 0.992 0.007
E74.1 Disorders of fructose metabolism
0.000 0.992 0.007
M65.2 Calcific tendinitis
0.000 0.992 0.007
M65.0 Abscess of tendon sheath
0.000 0.992 0.007
C92.9 Myeloid leukaemia, unspecified
0.000 0.993 0.007
D37.3 Appendix
0.000 0.993 0.007
D44.8 Pluriglandular involvement
0.000 0.993 0.007
C92.4 Acute promyelocytic leukaemia
0.000 0.993 0.007
D37.9 Digestive organ, unspecified
0.000 0.993 0.007
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.993 0.007
D37.1 Stomach
0.000 0.993 0.007
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.993 0.007
M65.1 Other infective (teno)synovitis
0.000 0.993 0.007
E34 Other endocrine disorders
0.000 0.993 0.007
D41.2 Ureter
0.000 0.993 0.007
E06.3 Autoimmune thyroiditis
0.000 0.993 0.007
D44.1 Adrenal gland
0.000 0.993 0.007
E67 Other hyperalimentation
0.000 0.993 0.007
E68 Sequelae of hyperalimentation
0.000 0.993 0.007
E74.0 Glycogen storage disease
0.000 0.993 0.007
E29 Testicular dysfunction
0.000 0.993 0.007
E34.9 Endocrine disorder, unspecified
0.000 0.993 0.007
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)
0.000 0.993 0.007
D42.9 Meninges, unspecified
0.000 0.993 0.007
D42.1 Spinal meninges
0.000 0.993 0.007
D42.0 Cerebral meninges
0.000 0.993 0.007
E00-E07 Disorders of thyroid gland
0.000 0.993 0.007
C92.0 Acute myeloid leukaemia
0.000 0.993 0.007
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.000 0.993 0.006
E72.0 Disorders of amino-acid transport
0.000 0.993 0.006
E10.9 Without complications
0.000 0.993 0.007
E26 Hyperaldosteronism
0.000 0.994 0.006
M65.84 Other synovitis and tenosynovitis (Hand)
0.000 0.994 0.006
E06 Thyroiditis
0.000 0.994 0.006
E25 Adrenogenital disorders
0.000 0.994 0.006
E20 Hypoparathyroidism
0.000 0.994 0.006
E85 Amyloidosis
0.000 0.994 0.006
M65.86 Other synovitis and tenosynovitis (Lower leg)
0.000 0.994 0.006
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.994 0.006
E29.1 Testicular hypofunction
0.000 0.994 0.006
M65.3 Trigger finger
0.000 0.994 0.006
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.994 0.006
E32 Diseases of thymus
0.000 0.994 0.006
E31 Polyglandular dysfunction
0.000 0.994 0.006
E30 Disorders of puberty, not elsewhere classified
0.000 0.994 0.006
D38.5 Other respiratory organs
0.000 0.994 0.006
M65.81 Other synovitis and tenosynovitis (Shoulder region)
0.000 0.994 0.006
E27 Other disorders of adrenal gland
0.000 0.994 0.006
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec
0.000 0.994 0.006
M65.48 Radial styloid tenosynovitis [de Quervain]-Other
0.000 0.994 0.006
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot
0.000 0.994 0.006
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg
0.000 0.994 0.006
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh
0.000 0.994 0.006
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm
0.000 0.994 0.006
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region
0.000 0.994 0.006
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)
0.000 0.994 0.006
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.994 0.006
E14.9 Without complications
0.000 0.994 0.006
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)
0.000 0.994 0.006
C90.2 Plasmacytoma, extramedullary
0.000 0.994 0.006
D37.2 Small intestine
0.000 0.994 0.006
M65.89 Other synovitis and tenosynovitis (Site unspecified)
0.000 0.994 0.006
M65.88 Other synovitis and tenosynovitis (Other)
0.000 0.994 0.006
M65.85 Other synovitis and tenosynovitis (Pelvic region and thigh)
0.000 0.994 0.006
M65.82 Other synovitis and tenosynovitis (Upper arm)
0.000 0.994 0.006
M65.80 Other synovitis and tenosynovitis (Multiple sites)
0.000 0.994 0.006
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.000 0.994 0.006
E34.8 Other specified endocrine disorders
0.000 0.994 0.006
C64 Malignant neoplasm of kidney, except renal pelvis
0.000 0.994 0.006
E03 Other hypothyroidism
0.000 0.994 0.006
D38.6 Respiratory organ, unspecified
0.000 0.994 0.005
D38.4 Thymus
0.000 0.994 0.005
D38.2 Pleura
0.000 0.994 0.005
M65.09 Abscess of tendon sheath (Site unspecified)
0.000 0.994 0.005
M65.08 Abscess of tendon sheath (Other)
0.000 0.994 0.005
M65.07 Abscess of tendon sheath (Ankle and foot)
0.000 0.994 0.005
M65.06 Abscess of tendon sheath (Lower leg)
0.000 0.994 0.005
M65.05 Abscess of tendon sheath (Pelvic region and thigh)
0.000 0.994 0.005
M65.04 Abscess of tendon sheath (Hand)
0.000 0.994 0.005
M65.03 Abscess of tendon sheath (Forearm)
0.000 0.994 0.005
M65.02 Abscess of tendon sheath (Upper arm)
0.000 0.994 0.005
M65.01 Abscess of tendon sheath (Shoulder region)
0.000 0.994 0.005
M65.00 Abscess of tendon sheath (Multiple sites)
0.000 0.994 0.005
M65.29 Calcific tendinitis (Site unspecified)
0.000 0.994 0.005
M65.28 Calcific tendinitis (Other)
0.000 0.994 0.005
M65.27 Calcific tendinitis (Ankle and foot)
0.000 0.994 0.005
M65.26 Calcific tendinitis (Lower leg)
0.000 0.994 0.005
M65.25 Calcific tendinitis (Pelvic region and thigh)
0.000 0.994 0.005
M65.24 Calcific tendinitis (Hand)
0.000 0.994 0.005
M65.23 Calcific tendinitis (Forearm)
0.000 0.994 0.005
M65.22 Calcific tendinitis (Upper arm)
0.000 0.994 0.005
M65.21 Calcific tendinitis (Shoulder region)
0.000 0.994 0.005
M65.20 Calcific tendinitis (Multiple sites)
0.000 0.994 0.005
K91.4 Colostomy and enterostomy malfunction
0.000 0.994 0.006
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.994 0.006
I12.9 Hypertensive renal disease without renal failure
0.000 0.994 0.005
D37.4 Colon
0.000 0.994 0.006
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.994 0.005
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.994 0.005
M65.19 Other infective (teno)synovitis (Site unspecified)
0.000 0.995 0.005
M65.18 Other infective (teno)synovitis (Other)
0.000 0.995 0.005
M65.17 Other infective (teno)synovitis (Ankle and foot)
0.000 0.995 0.005
M65.16 Other infective (teno)synovitis (Lower leg)
0.000 0.995 0.005
M65.15 Other infective (teno)synovitis (Pelvic region and thigh)
0.000 0.995 0.005
M65.13 Other infective (teno)synovitis (Forearm)
0.000 0.995 0.005
M65.12 Other infective (teno)synovitis (Upper arm)
0.000 0.995 0.005
M65.11 Other infective (teno)synovitis (Shoulder region)
0.000 0.995 0.005
M65.10 Other infective (teno)synovitis (Multiple sites)
0.000 0.995 0.005
E34.5 Androgen resistance syndrome
0.000 0.995 0.005
E34.4 Constitutional tall stature
0.000 0.995 0.005
E34.3 Short stature, not elsewhere classified
0.000 0.995 0.005
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.995 0.005
E34.1 Other hypersecretion of intestinal hormones
0.000 0.995 0.005
D47.1 Chronic myeloproliferative disease
0.000 0.995 0.005
D38.3 Mediastinum
0.000 0.995 0.005
E67.8 Other specified hyperalimentation
0.000 0.995 0.005
E67.3 Hypervitaminosis D
0.000 0.995 0.005
E67.2 Megavitamin-B6 syndrome
0.000 0.995 0.005
E67.1 Hypercarotenaemia
0.000 0.995 0.005
E67.0 Hypervitaminosis A
0.000 0.995 0.005

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.